patatin like domain 3, 1-acylglycerol-3-phosphate O-acyltransferase
Last updated 1 Apr 2026
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The PNPLA3 gene provides instructions for making an enzyme that is found in fat cells (adipocytes) and liver cells (hepatocytes). The liver is part of the digestive system, and it helps break down food, store energy, and remove waste products. The PNPLA3 enzyme is thought to help regulate the development of adipocytes and the production and breakdown of fats (lipogenesis and lipolysis) in adipocytes and hepatocytes. Studies indicate that the activity (expression) of the PNPLA3 gene decreases during periods without food (fasting) and increases after eating, suggesting that the PNPLA3 enzyme is produced as needed to help store or break down fats in the liver.
Normal function
The PNPLA3 gene provides instructions for making an enzyme that is found in fat cells (adipocytes) and liver cells (hepatocytes). The liver is part of the digestive system, and it helps break down food, store energy, and remove waste products. The PNPLA3 enzyme is thought to help regulate the development of adipocytes and the production and breakdown of fats (lipogenesis and lipolysis) in adipocytes and hepatocytes. Studies indicate that the activity (expression) of the PNPLA3 gene decreases during periods without food (fasting) and increases after eating, suggesting that the PNPLA3 enzyme is produced as needed to help store or break down fats in the liver.
Conditions referring to this gene or chromosome
Other names
acylglycerol O-acyltransferase
adiponutrin
ADPN
C22orf20
calcium-independent phospholipase A2-epsilon
patatin like phospholipase domain containing 3
Related patient information and medicines

Patient information leaflet
Can I take Adcal-D3 and Carbocisteine together?
Why this happens Adcal-D3 (calcium and vitamin D3) and carbocisteine (a mucolytic used to thin mucus) are processed by the body through different pathways. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. ...ns and what to do about themDisclaimer.

Patient information leaflet
Can I take Ginger and Vitamin C together?
Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice. Always consult your GP, pharmacist, or another.

Patient information leaflet
Can I take Devil's claw and Vitamin C together?
There are no known significant interactions between devil's claw and vitamin C. It is generally considered safe to take these two supplements together. Simply search for your medicines to see potential interactions and what to d... Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute.

Patient information leaflet
Can I take Adcal-D3 and Collagen together?
There is no known harmful interaction between Adcal-D3 and collagen supplements. In fact, they are often used together to support bone and joint health. Why this happens Adcal-D3 provides calcium and vitamin D3, while collagen provides amino acids. These substances are processed by the body through different pathways and do not interfere with each.

Patient information leaflet
Can I take Folic acid and Vitamin C together?
Simply search for your medicines to see potential interactions and w... Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice. Always consult your GP, pharmacist, or another qualified healthcare professional before making decisions about your medications..

Patient information leaflet
Can I take Adcal-D3 and Omega-3 together?
There is no known harmful interaction between Adcal-D3 and Omega-3 (fish oil) supplements. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. ...This information is for general educational purposes only and should not be relied upon as a substitute.
Further reading and references
- patatin like domain 3, 1-acylglycerol-3-phosphate O-acyltransferase; MedlinePlus, National Library of Medicine.
- Abdelsattar S, Al-Amodi HS, Kamel HFM, Kasemy ZA, Darwish E, Mosbeh A, Sakr AA, Elgazzar HM, Abdelkareem M, Abozeid M, Zewain SK, Bedair HM, Abdelmageed SM. Impact of genotyping (PTPN2, rs2542151) and (MBOAT7, rs641738) in prediction of fibrosis in Metabolic dysfunction- associated steatotic liver disease' patients. Front Endocrinol (Lausanne). 2025 Sep 11;16:1615162. doi: 10.3389/fendo.2025.1615162. eCollection 2025.
- Caligiuri A, Gentilini A, Marra F. Molecular Pathogenesis of NASH. Int J Mol Sci. 2016 Sep 20;17(9):1575. doi: 10.3390/ijms17091575.
- Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis. World J Gastroenterol. 2015 Jan 21;21(3):794-802. doi: 10.3748/wjg.v21.i3.794.
- Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol. 2013 Nov 7;19(41):6969-78. doi: 10.3748/wjg.v19.i41.6969.
- Elmansoury N, Megahed AA, Kamal A, El-Nikhely N, Labane M, Abdelmageed M, Daly AK, Wahid A. Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes (Basel). 2024 Apr 4;15(4):455. doi: 10.3390/genes15040455.
- Linden D, Tesz G, Loomba R. Targeting PNPLA3 to Treat MASH and MASH Related Fibrosis and Cirrhosis. Liver Int. 2025 Apr;45(4):e16186. doi: 10.1111/liv.16186. Epub 2024 Nov 28.
- Mancina RM, Valenti L, Romeo S. Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism. Nat Metab. 2025 Nov;7(11):2199-2211. doi: 10.1038/s42255-025-01394-8. Epub 2025 Oct 17.
- Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol. 2016 Aug 7;22(29):6742-56. doi: 10.3748/wjg.v22.i29.6742.
- Tavaglione F, Pennisi G, Pelusi S. PNPLA3 I148M and Hepatocellular Carcinoma. Liver Int. 2025 Apr;45(4):e70051. doi: 10.1111/liv.70051.
- Yu J, Marsh S, Hu J, Feng W, Wu C. The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterol Res Pract. 2016;2016:2862173. doi: 10.1155/2016/2862173. Epub 2016 May 9.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

